140 related articles for article (PubMed ID: 1931896)
1. Immunohistochemical analysis of estrogen and progesterone receptors in benign breast diseases.
Tóth J; De Sombre ER; Greene GL
Zentralbl Pathol; 1991; 137(3):227-32. PubMed ID: 1931896
[TBL] [Abstract][Full Text] [Related]
2. [Steroid hormone receptors in mammary carcinoma. Immunohistochemical detection and prognostic significance].
Reiner A; Neumeister B; Reiner G; Jakesz R; Kolb R; Schemper M; Spona J
Zentralbl Pathol; 1991; 137(3):233-41. PubMed ID: 1657132
[TBL] [Abstract][Full Text] [Related]
3. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
Gatalica Z
Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
[TBL] [Abstract][Full Text] [Related]
5. Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study.
Wilbur DC; Barrows GH
Mod Pathol; 1993 Mar; 6(2):114-20. PubMed ID: 8097877
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of C-erbB-2 and hormone receptors' status in human benign and malignant breast lesions.
Goussia A; Agnantis NJ; Athanassiadou S; Stefanou D
Anticancer Res; 1995; 15(5B):2313-8. PubMed ID: 8572645
[TBL] [Abstract][Full Text] [Related]
7. [Content of 17 beta éstradiol, progesterone and glucocorticoid receptors in patients with benign breast diseases].
Bassalyk LS; Kuz'mina ZV; Murav'eva NI; Smirnova KD; Vishniakova VV
Vopr Onkol; 1982; 28(7):3-6. PubMed ID: 7101825
[TBL] [Abstract][Full Text] [Related]
8. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC).
Beck T; Weikel W; Brumm C; Wilkens C; Pollow K; Knapstein PG
Gynecol Oncol; 1994 May; 53(2):220-7. PubMed ID: 8188083
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry.
van Agthoven T; Timmermans M; Foekens JA; Dorssers LC; Henzen-Logmans SC
Am J Pathol; 1994 Jun; 144(6):1238-46. PubMed ID: 7515559
[TBL] [Abstract][Full Text] [Related]
11. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer.
Reiner A; Neumeister B; Spona J; Reiner G; Schemper M; Jakesz R
Cancer Res; 1990 Nov; 50(21):7057-61. PubMed ID: 2208173
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical correlation of steroid receptors and disease-free interval in 206 consecutive cases of breast cancer: validation of telequantification based on global scene segmentation.
Ferrer Roca OF; Ramos A; Diaz Cardama A
Anal Cell Pathol; 1995 Sep; 9(2):151-63. PubMed ID: 7492518
[TBL] [Abstract][Full Text] [Related]
14. Receptors for estrogen and progesterone in breast carcinoma in situ.
Pallis L; Wilking N; Cedermark B; Rutqvist LE; Skoog L
Anticancer Res; 1992; 12(6B):2113-5. PubMed ID: 1295456
[TBL] [Abstract][Full Text] [Related]
15. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
[TBL] [Abstract][Full Text] [Related]
16. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
[TBL] [Abstract][Full Text] [Related]
17. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
[TBL] [Abstract][Full Text] [Related]
18. [Detection of steroid hormone receptors in patients with mastopathies and fibroadenomas].
Meissner J; Kasch R; Splitt G; Gerber B; Rhode E
Zentralbl Gynakol; 1989; 111(23):1562-6. PubMed ID: 2624008
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
[TBL] [Abstract][Full Text] [Related]
20. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
